---
figid: PMC9407780__ijms-23-08863-g001
pmcid: PMC9407780
image_filename: ijms-23-08863-g001.jpg
figure_link: /pmc/articles/PMC9407780/figure/ijms-23-08863-f001/
number: Figure 1
figure_title: ''
caption: VEGF activation and signaling pathway. The VEGF protein family includes VEGF-A,
  -B, -C, -D, and -E. VEGF-A binds to VEGFR1 homo-, VEGFR2 homo- and VEGFR1/R2 hetero-dimers,
  VEGF-B binds to VEGFR1 homodimers, VEGF-C and -D bind to VEGFR3 homodimers and VEGF-E
  binds to VEGFR2 homodimers.
article_title: Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer
  (NSCLC).
citation: Aaron C. Tan, et al. Int J Mol Sci. 2022 Aug;23(16):8863.
year: '2022'

doi: 10.3390/ijms23168863
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- anaplastic lymphoma kinase
- ALK rearrangement
- anti-angiogenesis
- non-small cell lung cancer
- vascular endothelial growth factor

---
